PDLIM7 and neoplasm: Antibodies to Ym1/2 have been described to occur also in a model of incipient neoplasia in mice overexpressing the Epstein Barr virus oncogene LMP1 in the skin, leading to chronic inflammation (Qureshi et al., 2011).